Literature DB >> 3142266

Filtering bleb thrombolysis with tissue plasminogen activator.

J R Ortiz1, S D Walker, P E McManus, L A Martinez, R H Brown, G J Jaffe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3142266     DOI： 10.1016/0002-9394(88)90598-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  6 in total

1.  Tissue plasminogen activator therapy for the eye.

Authors:  R C Tripathi; B J Tripathi
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

2.  Very late-onset flap margin corneal ulcer following laser in situ keratomileusis.

Authors:  Gilad Rabina; Nur Azem; Michael Mimouni; Idan Hecht; David Varssano
Journal:  Int Ophthalmol       Date:  2019-04-13       Impact factor: 2.031

3.  The use of tissue plasminogen activator in postvitrectomy cases.

Authors:  C Koutsandrea; M Apostolopoulos; P Theodossiadis
Journal:  Int Ophthalmol       Date:  1993-04       Impact factor: 2.031

4.  193 nm excimer laser sclerostomy in pseudophakic patients with advanced open angle glaucoma.

Authors:  B D Allan; P P van Saarloos; R L Cooper; I J Constable
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

5.  Promotion of glaucoma filter bleb with tissue plasminogen activator after sclerectomy under a clot.

Authors:  A Szymanski
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

6.  Corneal endothelial permeability in protection glaucoma filter bleb with tissue plasminogen activator.

Authors:  A Szymanski; A Gierek-Lapinska; M Koziak; S Gierek-Kalicka
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.